Project Cattedra - Interreg V-A Italy-Slovenia 2014-2020 - Final Meeting
Data e ora
TOWARDS BETTER CARE FOR AUTOIMMUNE AND AUTOINFLAMMATORY DISEASES IN CHILDREN
Informazioni sull'evento
8.00-8.45 Participants Registration
8.45-9.00 Opening of the Meeting
Scientific part 1 (20’ + 5’ of discussion)
Moderators: Andrea Taddio (Trieste); Natasa Toplak (Ljubljana)
9.00-9.25 How to identify a child with JIA and how to avoid the most frequent pitfalls in differential diagnosis. (Serena Pastore, Trieste)
9.25-9.50 Assessment of disease activity and approach to clinical management of JIA (Mojca Zajc Avramovič, Ljubljana)
9.50-10.15 Classical and atypical clinical manifestations of JDM (Marco Cattalini, Brescia)
10.15-10.40 A practical approach to Inflammatory Myositis (Gabriele Simonini, Firenze)
10.40-11.10: Coffe Break
11.10-11.35 When to think about Systemic Lupus Erythematosus: Renal involvement and beyond. (Lovro Lamot, Zagreb)
11.35-12.00 Systemic Lupus Erythematosus: old and new treatment strategies (Tadej Avčin, Ljubljana)
Public part
12.00-12.10 Presentation of Cattedra Project
Presentation of Partners
12.10-12.20 Better presentation
12.20-12.30 Experteam presentation
12.30-12.40 Cobik presentation
12.40-13.00 Cattedra project after Cattedra project (open discussion with all partners)
13.00-14.15 Lunch
Scientific part 2 (20’ + 5’ of discussion)
Moderators: Tadej Avcin (Ljubljana); Alberto Tommasini (Trieste)
14.15-14.40 Epidemiology of MIS-C and other autoimmune diseases after SARS-CoV-2 infection (Maša Bizjak, Ljubljana)
14.40-15.05 MIS-C and Kawasaki Disease: clinical manifestations and treatment options (Andrea Taddio, Trieste)
15.05-15.30 What we know about MIS-C from genetic and laboratory data (Barbara Jenko Bizjan, Ljubljana)
15.30-16.00: Coffe Break
Scientific part 3 (20’ + 5’ of discussion)
Moderators: Serena Pastore (Trieste); Mojca Zajc Avramovič (Ljubljana)
16.00-16.25 Clinical implication of type I interferon signature and clinical implications (Alessandra Tesser, Trieste)
16.25-16.50 Vaccination in children affected by rheumatologic diseases: when is it safe, when it is not (Nataša Toplak, Ljubljana)
16.50-17.15 Pulmonary Involvement in pediatric rheumatology (Sergio Ghirardo, Udine)
17.15-17.30 Final remarks